Skip to main content
OpenTrials
Completed

NCT Number: NCT02183116

A Study to Access the Efficacy and Safety of Meloxicam in Patients With Osteoarthritis of the Knee

To Access the Efficacy and Safety of Meloxicam 7.5mg once daily over a treatment period of 56 days

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Osteoarthritis Arthritis Joint Diseases Musculoskeletal Diseases Rheumatic Diseases

Age range

34 year–74 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Osteoarthritis of the knee requiring the therapy with non-steroidal anti-inflammatory drugs (NSAIDs)

Exclusion criteria

none

Treatment and study plan

Meloxicam

Drug

Other names: Mobic

Primary outcomes

  1. Change from baseline in pain on active movement assessed by a 100 mm visual analogue scale (100 mm, VAS)

    Time frame: Baseline, 8 weeks after first drug administration

Secondary outcomes

  1. Change from baseline in Lequesne index

    Time frame: Baseline, 8 weeks after first drug administration

  2. Change from baseline in physical examination (tenderness)

    Time frame: Baseline, 8 weeks after first drug administration

  3. Assessment of significant change from baseline in status according endoscopy

    Time frame: Baseline, 8 weeks after first drug administration

  4. Assessment of significant change from baseline in gastrointestinal (GI) symptoms score

    Time frame: Baseline, 8 weeks after first drug administration

  5. Assessment of significant change from baseline in laboratory values

    Time frame: Baseline, 8 weeks after first drug administration

  6. Number of Patients with Adverse Events

    Time frame: Up to 8 weeks after first drug administration

  7. Assessment of significant change from baseline in physical examination (swelling)

    Time frame: Baseline, 8 weeks after treatment

Sponsors and collaborators

Lead sponsor

Boehringer Ingelheim

Industry

Registry information

Official study title

Open Study to Access the Efficacy and Safety of Meloxicam 7.5mg in Patients With Osteoarthritis of the Knee

Important dates

Study start
1998
Primary completion
1999
First posted
Jul 8, 2014
Registry last updated
Jul 8, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.